Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04319497
Other study ID # Refraction
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 20, 2013
Est. completion date August 20, 2014

Study information

Verified date March 2020
Source Vienna Institute for Research in Ocular Surgery
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Targeting of post-cataract refraction depends mainly on the prediction of the post-operative lens position, but also on the post-operative refraction itself. Hence, aim of this study is to evaluate the agreement and variability of subjective refraction performed by two independent examiners, autorefraction, and wavefront aberrometry in pseudophakic patients after uneventful cataract surgery.


Description:

One of the main goals of modern cataract surgery, beside removing the cataractous lens, is to achieve the patient's desired post-operative refraction. Targeting this post-operative refraction depends mainly on the prediction of the post-operative lens position and the post-operative refraction itself. Reason for the contributing effect of post-operative refraction in the error-propagation analyses is that refraction in phakic patients was shown to have only moderate reproducibility.

In the past, different studies evaluated refraction methods. However, there is no study that included reproducibility of subjective refraction in pseudophakic patients and compares it with objective refraction methods (autorefraction, wavefront aberrometry).

100 eyes of 100 patients, which underwent uneventful cataract surgery, will be included in the study. Refraction of one eye of each patient will be tested using subjective refraction by two different examiners, autorefraction, and wavefront aberrometry at two separate occasions.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date August 20, 2014
Est. primary completion date August 20, 2014
Accepts healthy volunteers No
Gender All
Age group 21 Years to 105 Years
Eligibility Inclusion Criteria:

- Minimum age: 21 years

- Cataract surgery (at least 8 weeks post-surgery)

- written informed consent

Exclusion Criteria:

- Complications during or after cataract surgery

- Ophthalmic diseases, that might interfere with measurements (macular degeneration, glaucoma, diabetic retinopathia)

- Ophthalmic surgery other than cataract surgery

- Clinically significant posterior capsule opacification

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Subjective refraction
Subjective refraction measurements will be performed by two testers for all the patients included
Autorefraction
Five autorefraction measurements will be performed for all the patients included
Wavefront aberrometry
Five wavefront measurements will be performed for all the patients included

Locations

Country Name City State
Austria Vienna Institute for Research in Ocular Surgery (VIROS) Vienna

Sponsors (1)

Lead Sponsor Collaborator
Vienna Institute for Research in Ocular Surgery

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the agreement between the subjective refraction measurements (in dioptres) of two examiners To show the number of measurements within the limits of agreement, Bland-Altman plots will be created for subjective refraction measurements in dioptres between examiner 1 and examiner 2. 12 months
Secondary Evaluation of reproducibility between the subjective refraction measurements between two study visits To compare reproducibility of subjective refraction measurements between study visit 1 and study visit 2 Wilcoxon-signed rank test will be applied. 12 months
Secondary Evaluation of the agreement between the measurements performed by subjective refraction, autorefraction, and wavefront aberrometry (in dioptres) To show the number of measurements within the limits of agreement, Bland-Altman plots will be created for subjective refraction measurements in dioptres between the 3 measurement methods. 12 months
Secondary Evaluation of the reproducibility between measurements done with subjective refraction, autorefraction, and wavefront aberrometry in dioptres To compare reproducibility between the 3 measurement methods in dioptres, Friedman's multiple comparison will be applied. 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT01193504 - Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification Phase 4
Completed NCT00347243 - Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical Intraocular Lenses Phase 4
Completed NCT04208633 - Correlation Between Sulcus Anatomy and Other Parameters After Horizontal & Vertical Intraocular Lens (IOLs) Placements N/A
Recruiting NCT06041139 - Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy
Completed NCT04533191 - Binocular Custom Vision Utilizing The Light Adjustable Lens (LAL)
Completed NCT05735990 - Retrospective Clinical Investigation of the Safety and Performance of 640PM Trifocal IOL Implantation in Patients With Cataract and/or Ametropia (Hyperopia, Myopia) and/or Presbyopia
Recruiting NCT04175951 - Tecnis Eyhance Versus Rayner RayOne Study N/A
Not yet recruiting NCT06056154 - Safety and Efficacy of the Hydrophobic Intraocular Lens AsqelioTM Monofocal With Biaspheric Design
Not yet recruiting NCT05531110 - Comparison of Two Aspheric Intraocular Lenses for Micro-monovision N/A
Completed NCT01004549 - An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular Lenses N/A
Recruiting NCT03823092 - Polarization Perception in Health and Disease. Testing a New Sight Test
Completed NCT05226884 - Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
Completed NCT01310127 - Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Phase 4
Completed NCT05335408 - Evaluation of Visual Function After Bilateral Implantation of EDOF IOLs N/A
Completed NCT05611073 - Maximizing Visual Outcomes With Eyhance IOLs
Completed NCT05418153 - Synergy Lens Outcomes Evaluation
Recruiting NCT06065072 - Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900
Completed NCT02450799 - Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation N/A
Completed NCT00428363 - Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification Phase 4
Completed NCT04468022 - Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment N/A